ICA Group Wealth Management’s Gilead Sciences GILD Stock Holding History

ICA Group Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-973	Closed	-$71.3K	–	983
2024 Q1	$71.3K	Sell	973 -7	-0.7%	-$538	0.01%	478
2023 Q4	$79.4K	Buy	+980	New	+$76.3K	0.02%	411
2023 Q3	–	Sell	-786	Closed	-$60.6K	–	606
2023 Q2	$60.6K	Buy	786 +94	+14%	+$7.5K	0.02%	456
2023 Q1	$57.4K	Sell	692 -210	-23%	-$17.4K	0.01%	459
2022 Q4	$77.4K	Sell	902 -2,379	-73%	-$188K	0.02%	416
2022 Q3	$202K	Buy	+3,281	New	+$207K	0.04%	340

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ICA Group Wealth Management's GILD Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 973 shares — an estimated $71.3K sold.

ICA Group Wealth Management first reported a position in GILD in Q3 2022 and held it in 6 quarters. The position peaked at $202K in Q3 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

ICA Group Wealth Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
ICA Group Wealth Management sold 973 Gilead Sciences shares in Q2 2024, an estimated $71.3K.
ICA Group Wealth Management first reported a position in Gilead Sciences in Q3 2022 and held it in 6 quarters.
ICA Group Wealth Management's Gilead Sciences position peaked at $202K in Q3 2022.
1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.